Abstract:Lipid nanoparticles (LNPs) are a type of lipid vesicles that possess a homogeneous lipid core. These vesicles are widely used in small-molecule drug and nucleic acid delivery and recently gained much attention because of their remarkable success as a delivery platform for COVID-19 mRNA vaccines. Nonetheless, the utility of transient protein expression induced by mRNA extends far beyond vaccines against infectious diseases─they also hold promise as cancer vaccines, protein replacement therapies, and gene editing components for rare genetic diseases. However, naked mRNA is inherently unstable and prone to rapid degradation by nucleases and self-hydrolysis. Encapsulation of mRNA within LNPs protects mRNA from extracellular ribonucleases and assists with intracellular mRNA delivery.In this Account, we discuss the core features of LNPs for RNA delivery. We focus our attention on LNPs designed to deliver mRNA; however, we also include examples of siRNA-LNP delivery where appropriate to highlight the commonalities and the dissimilarities due to the nucleic acid structure. First, we introduce the concept of LNPs, the advantages and disadvantages of utilizing nucleic acids as therapeutic agents, and the general reasoning behind the molecular makeup of LNPs. We also briefly highlight the most recent clinical successes of LNP-based nucleic acid therapies. Second, we describe the theory and methods of LNP self-assembly. The common idea behind all of the preparation methods is inducing electrostatic interactions between the nucleic acid and charged lipids and promoting nanoparticle growth via hydrophobic interactions. Third, we break down the LNP composition with special attention to the fundamental properties and purposes of each component. This includes the identified molecular design criteria, commercial sourcing, impact on intracellular trafficking, and contribution to the properties of LNPs. One of the key components of LNPs is ionizable lipids, which initiate electrostatic binding with endosomal membranes and facilitate cytosolic release; however, the roles of other lipid components should not be disregarded, as they are associated with stability, clearance, and distribution of LNPs. Fourth, we review the attributes of LNP constructs as a whole that can heavily influence RNA delivery. These attributes are LNP size, charge, internal structure, lipid packing, lipid membrane hydration, stability, and affinity toward biomacromolecules. We also discuss the specific techniques used to examine these attributes and how they can be adjusted. Finally, we offer our perspective on the future of RNA therapies and some questions that remain in the realm of LNP formulation and optimization.

Lipid Nanoparticle Spherical Nucleic Acids For Intracellular Dna And Rna Delivery

Lipid Nanoparticle (LNP) Chemistry Can Endow Unique in Vivo RNA Delivery Fates Within the Liver That Alter Therapeutic Outcomes in a Cancer Model

Lipid Nanoparticles for Broad‐Spectrum Nucleic Acid Delivery

Structure-Dependent Biodistribution of Liposomal Spherical Nucleic Acids

Chemistry of Lipid Nanoparticles for RNA Delivery

PLGA Spherical Nucleic Acids.

Nucleic Acid-Mediated Intracellular Protein Delivery by Lipid-Like Nanoparticles.

A Combinatorial Library of Lipid Nanoparticles for RNA Delivery to Leukocytes

Comparison of ionizable lipids for lipid nanoparticle mediated DNA delivery

Liquid crystalline inverted lipid phases encapsulating siRNA enhance lipid nanoparticle mediated transfection

Lipid Nanoparticles Optimized for Targeting and Release of Nucleic Acid

Lipid Nanoparticles for Nucleic Acid Delivery to Endothelial Cells

Design of Peptidomimetic Functionalized Cholesterol Based Lipid Nanoparticles for Efficient Delivery of Therapeutic Nucleic Acids

DNA nanoclew templated spherical nucleic acids for siRNA delivery

Cytosolic delivery of nucleic acids: The case of ionizable lipid nanoparticles

Optimized Lipid Nanoparticles (lnps) for Organ-Selective Nucleic Acids Delivery in Vivo

Lipid Nanoparticles for Hepatic Delivery of Small Interfering Rna

Intracellular Fate of Spherical Nucleic Acid Nanoparticle Conjugates

Original Synthesis of a Nucleolipid for Preparation of Vesicular Spherical Nucleic Acids

Lipid Nanoparticles for Nucleic Acid Delivery Beyond the Liver

A Combinatorial Library of Lipid Nanoparticles for Cell Type‐Specific mRNA Delivery